Clinical ink’s Senior Product Manager Liz Goodman co-leads the EFGCP eConsent library workstream with other industry experts. Learn about their efforts over the year as featured in the harmonized eConsent glossary and article in Applied Clinical Trials https://t.co/3y8hhlIeDu
Access expert insights into the latest in patient adherence and dropout prevention strategies in our on-demand webinar. Watch Now: https://t.co/cu4ritYv3r
Happening today – our webinar on the impact of social factors on health outcomes for cardiometabolic diseases and exploring how digital therapeutics can elevate drug treatments. Register Now. https://t.co/cu4ritZ2SZ
#SDoH#DigitalTherapeutics#ClinicalTrials#PatientCentered
Explore how patient behavior enhances trial effectiveness in our Dec 5 webinar. Discover the impact on outcomes and experiences.
Join now: https://t.co/cu4ritYv3r
Discover why combining behavioral, psychometric, & social metrics revolutionizes trials. Join our Dec 5 webinar for key insights.
Save your seat: https://t.co/cu4ritYv3r
#ClinicalTrials
Uncover how deep insights into patient behavior boost clinical research. Join our Dec 5 webinar for more expert strategies.
Register now: https://t.co/cu4ritYv3r
#ClinicalTrials
Explore the latest strategies in digital health in our recent article on boosting patient engagement and tackling health inequalities in clinical trials.
Dive in now: https://t.co/8b3Z0hBXGj
#ClinicalTrials#PatientEngagement
Join experts to discuss how patient engagement, SDoH, and digital therapeutics shape effective interventions for obesity, diabetes, and heart disease. Register for webinar: https://t.co/cu4ritYv3r
#SDoH#digitaltherapeutics#ClinicalTrials#PatientCentered
Take advantage of an opportunity to learn from our experts on how to improve cardiometabolic clinical trials with behavioral science and digital therapeutics. Register for this free webinar.
#ClinicalTrials#CardiometabolicClinicalResearch
FDA's new PRO guidance elevates patient voices in cancer research. At Clinical ink, we're committed to integrating these insights into drug development. Explore our patient-centered approach. #ClinicalTrials#FDA
https://t.co/5pgFTD5lol
We are excited to partner with @Observia_Esante by integrating SPUR™ into our technology to enhance patient behavior insights, boosting engagement & trial efficiency.
To learn more: https://t.co/VpWXJLEsZj
#HealthTech#PatientEngagement#ClinicalTrials
Clinical ink and Observia join forces using advanced behavioral diagnostics to streamline processes and improve patient adherence and trial performance. Discover how we're shaping patient-centric trials.
#ClinicalTrials#DigitalHealth#PatientEngagement
https://t.co/VpWXJLEsZj
Unlock faster, more accurate study builds in just 10 days with our eCOA solution: streamlined visibility, adaptive design, seamless translations, and a tailored library. Dive in now: https://t.co/fgx51jp6Tb
#ClinicalResearch#eCOA
Does DDC ease site burdens? What's its effect on monitoring? How do decentralized trials impact EDC & DDC? Join Clinical ink's Megan Petrylak to discuss pros & cons of EDC vs DDC.
https://t.co/gHa0puSoRA
Our latest blog dives into FDA & EMA guidance, highlighting the power of combining tech and human insights in clinical trials. Learn why a hybrid approach, patient training, timely data management, and more are essential for success.
https://t.co/R0g1DH6J7n
Clinical ink enhances Data Management & Integrity services with key senior hires who bring extensive leadership experience to enhance delivery of clinical trials: Bock building & leading data management teams; Haag in digital health & data integrity. https://t.co/e2Mi9ypNh1
eCOA is revolutionizing the clinical research landscape. Clinical ink leads the way with smarter, faster solutions and higher quality data management. Learn how the eCOA system is thoroughly tested to guarantee reliability.
#ClinicalTrials#Clinicalink
https://t.co/hYoytVcTwz